Fibroblastic/myofibroblastic tumours: Difference between revisions
Jump to navigation
Jump to search
| Line 173: | Line 173: | ||
*Beta-catenin +ve (nuclear<ref name=pmid23020601/>) - '''important'''. | *Beta-catenin +ve (nuclear<ref name=pmid23020601/>) - '''important'''. | ||
*SMA +ve ~50% of lesions. | *SMA +ve ~50% of lesions. | ||
*CD117 -ve. | |||
==Lipofibromatosis== | ==Lipofibromatosis== | ||